TIL (Instil Bio, Inc.) — Stock Analysis, Catalysts & AI Research

Instil Bio, Inc.

$7.70

Health CareBiotechnology

Price

Overlays

Panel

TIL

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Scouting Reports

Weekly Playbook: Margin Durability and Regulatory Hurdles Across the Consumer-Tech-Utility Triad

May 11, 2026

A constructive tone has taken hold of broader markets heading into the new week, following a tech-led rally that saw the Nasdaq Composite finish last Friday up 1.71% as investors looked past near-term

Consumers Are Still Spending — but the Mix Is Narrowing

Apr 30, 2026

The core message in Consumer Spending Resilience With Emerging Cracks is not that the consumer has rolled over. It is that spending is still happening, but the mix is getting narrower: staples, value,

Create your free account to unlock active Expected Moves for TIL

Expected Moves

Instil Bio, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Scouting Reports

Weekly Playbook: Margin Durability and Regulatory Hurdles Across the Consumer-Tech-Utility Triad

Consumers Are Still Spending — but the Mix Is Narrowing

Create your free account to unlock active Expected Moves for TIL

Expected Moves

Instil Bio, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Scouting Reports

Weekly Playbook: Margin Durability and Regulatory Hurdles Across the Consumer-Tech-Utility Triad

Consumers Are Still Spending — but the Mix Is Narrowing